Comparison of Early Vs Delayed Beta Blocker Initiation in Acute Myocardial Infarction and's impact on left ventricular ejection fraction recovery
Early vs Delayed Beta-Blockers in AMI
DOI:
https://doi.org/10.69750/dmls.02.010.0158Keywords:
Acute myocardial infarction, Beta-blockers, Left ventricular ejection fraction, Early initiation, Cardiac remodeling, Ventricular arrhythmiaAbstract
Background: Beta-blockers are an established cornerstone in the management of acute myocardial infarction (AMI) due to their cardioprotective, antiarrhythmic, and anti-remodeling effects. However, the optimal timing of their initiation remains clinically debated, particularly regarding their impact on left ventricular ejection fraction (LVEF) recovery.
Objective: To compare early (within 24 hours) versus delayed (after 72 hours) initiation of beta-blockers in patients with acute myocardial infarction and to assess their effects on LVEF recovery and short-term clinical outcomes.
Methods: This comparative cross-sectional study was conducted at the Punjab Institute of Cardiology, Lahore, Pakistan, from July 2024 to July 2025. A total of 70 patients aged 35–70 years with confirmed AMI were enrolled and divided equally into two groups. Group A received beta-blockers within 24 hours, while Group B received them after 72 hours. LVEF was measured using echocardiography at baseline and at three-month follow-up. Secondary outcomes included arrhythmias, readmissions, and mortality.
Results: Baseline characteristics were similar between groups. Mean LVEF improved significantly in Group A (38.5 ± 5.3% to 49.8 ± 6.2%) compared to Group B (38.9 ± 5.1% to 44.1 ± 5.9%, p < 0.001). Early initiation also reduced ventricular arrhythmias (5.7% vs. 17.1%) and readmission rates (8.6% vs. 20%). No significant differences in bradycardia or hypotension were noted.
Conclusion: Early initiation of beta-blockers within 24 hours after AMI leads to superior LVEF recovery and fewer arrhythmic events compared to delayed therapy. Early beta-blockade should be encouraged in all hemodynamically stable AMI patients.
Downloads
References
Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44(29):2500-2596. doi:10.1093/eurheartj/ehad166
O’Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, et al. 2022 AHA/ACC Key Data Elements and Definitions for Acute Coronary Syndromes. Circulation. 2022;146(6):e95-e157. doi:10.1161/CIR.0000000000001057
Bangalore S, Makani H, Radford M, Thakur K, Messerli FH. Beta-blockers after myocardial infarction: systematic review and meta-analysis. J Am Coll Cardiol. 2020;76(9):1060-1070. doi:10.1016/j.jacc.2020.07.007
Puymirat E, Riant E, Aissaoui N, et al. Association of beta-blocker therapy with outcomes in patients with acute myocardial infarction and preserved ejection fraction. Eur Heart J. 2022;43(17):1639-1651. doi:10.1093/eurheartj/ehac045
Huang BT, et al. Timing of β-blocker initiation after acute myocardial infarction and short-term outcomes. Heart. 2020;106(8):607-613. doi:10.1136/heartjnl-2019-315860
Goldberger JJ, et al. Early versus late initiation of β-blockers post-AMI: an observational analysis. J Am Coll Cardiol. 2021;77(3):286-296. doi:10.1016/j.jacc.2020.11.012
Zhang Q, Wu C, Zhang Y, et al. Comparative outcomes of early and delayed beta-blocker initiation after STEMI: a multicenter analysis. Am Heart J. 2021;238:15-24. doi:10.1016/j.ahj.2021.04.004
Kondo T, et al. Predictors of improved left ventricular ejection fraction following acute myocardial infarction treated with beta-blockers. J Cardiol. 2023;82(3):204-211. doi:10.1016/j.jjcc.2023.01.010
Park JJ, et al. β-blockers in heart failure and post-MI remodeling: clinical insights. Heart Fail Clin. 2021;17(1):63-76. doi:10.1016/j.hfc.2020.08.003
Dondo TB, Hall M, West RM, et al. Beta-blocker therapy and mortality after acute myocardial infarction: contemporary UK registry analysis. BMJ. 2021;373:n160. doi:10.1136/bmj.n160
Kołodziejczak M, et al. Impact of β-blocker use on long-term outcomes after myocardial infarction: a meta-analysis. Eur J Prev Cardiol. 2020;27(10):1107-1116. doi:10.1177/2047487319854095
Hjalmarson Å, et al. β-blockers in acute myocardial infarction revisited: 40 years of evidence. Lancet. 2020;395(10224):171-180. doi:10.1016/S0140-6736(19)32927-8
Hong Y, et al. Early β-blocker initiation and ventricular arrhythmia prevention after MI: an updated meta-analysis. Int J Cardiol. 2022;356:33-39. doi:10.1016/j.ijcard.2022.02.052
Niccoli G, et al. Clinical outcomes with early versus delayed beta-blocker therapy post-reperfusion. JACC Cardiovasc Interv. 2021;14(14):1603-1615. doi:10.1016/j.jcin.2021.04.047
Abdel-Qadir H, et al. Long-term beta-blocker therapy in older adults after myocardial infarction. Circulation. 2023;147(9):754-765. doi:10.1161/CIRCULATIONAHA.122.061091
Wakabayashi K, et al. Effect of beta-blocker dose and timing on left ventricular remodeling after AMI. ESC Heart Fail. 2021;8(6):4807-4815. doi:10.1002/ehf2.13600
Vranckx P, et al. Pharmacologic optimization of post-MI care: balancing beta-blocker timing and reperfusion. Eur Heart J. 2022;43(11):1124-1134. doi:10.1093/eurheartj/ehac034
Niccoli G, Montone RA, Sabato V, et al. Mechanistic links between sympathetic activation and adverse remodeling after MI. JACC Basic Transl Sci. 2021;6(10):852-865. doi:10.1016/j.jacbts.2021.08.007
Smith JG, et al. Beta-blocker withdrawal or delay and risk of ventricular dysfunction post-AMI. Heart. 2020;106(19):1473-1481. doi:10.1136/heartjnl-2020-316997
Li Y, et al. Early beta-blocker administration in STEMI patients undergoing PCI: impact on cardiac function and outcomes. Front Cardiovasc Med. 2024;11:1458239. doi:10.3389/fcvm.2024.1458239
Downloads
PlumX Metrics
Published
Issue
Section
How to Cite
